$TFC·4

BB&T CORP · Aug 2, 4:15 PM ET

BB&T CORP 4

4 · BB&T CORP · Filed Aug 2, 2013

Insider Transaction Report

Form 4
Period: 2013-07-31
WILSON CHARLES L
Sr. Executive Vice President
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-07-3181,18420,297 total
    Exercise: $16.88From: 2010-02-24Exp: 2019-02-24Common Stock (81,184 underlying)
  • Exercise/Conversion

    Common Stock

    2013-07-31$16.88/sh+81,184$1,370,386226,659.974 total
  • Sale

    Common Stock

    2013-07-31$35.88/sh81,184$2,912,533145,475.974 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    59,734.363
  • Stock Option (right to buy)

    Exercise: $39.73From: 2007-02-21Exp: 2016-02-21Common Stock (51,684 underlying)
    51,684
  • Stock Option (right to buy)

    Exercise: $30.09From: 2013-02-21Exp: 2022-02-21Common Stock (47,685 underlying)
    47,685
  • Stock Option (right to buy)

    Exercise: $27.75From: 2011-02-23Exp: 2020-02-23Common Stock (49,350 underlying)
    49,350
  • Stock Option (right to buy)

    Exercise: $36.68From: 2005-02-24Exp: 2014-02-24Common Stock (41,363 underlying)
    41,363
  • Stock Option (right to buy)

    Exercise: $34.29From: 2009-02-26Exp: 2018-02-26Common Stock (73,295 underlying)
    73,295
  • Stock Option (right to buy)

    Exercise: $30.08From: 2014-02-26Exp: 2023-02-26Common Stock (26,952 underlying)
    26,952
  • Common Stock

    (indirect: By Son)
    1,484.051
  • Stock Option (right to buy)

    Exercise: $44.15From: 2008-02-20Exp: 2017-02-20Common Stock (56,785 underlying)
    56,785
  • Stock Option (right to buy)

    Exercise: $38.64From: 2006-02-22Exp: 2015-02-22Common Stock (55,253 underlying)
    55,253
  • Stock Option (right to buy)

    Exercise: $27.73From: 2012-02-22Exp: 2021-02-22Common Stock (38,006 underlying)
    38,006
Footnotes (14)
  • [F1]Includes 0.014 shares acquired between March 2013 and June 2013, under the Issuer's Dividend Reinvestment Plan.
  • [F10]The option is exercisable in four equal annual installments beginning on 2/22/2012.
  • [F11]The option is exercisable in four equal annual installments beginning on 02/23/2011.
  • [F12]The option is exercisable in five equal annual installments beginning on 2/24/2005.
  • [F13]The option is exercisable in five equal annual installments beginning on 2/26/2009.
  • [F14]The option is exercisable in three equal annual installments beginning on 02/26/2014.
  • [F2]The price in Column 4 is a weighted average price. The prices actually received ranged from $35.75 to $36.09. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]Includes 999.337 shares acquired between January 1, 2013 and June 30, 2013, under the Issuer's 401(k) Plan. The information in this report is based on plan statements dated January 1, 2013 through June 30, 2013.
  • [F4]Includes 21.290 shares acquired between March 2013 and June 2013, under the Issuer's Dividend Reinvestment Plan.
  • [F5]The option is exercisable in five equal annual installments beginning on 02/24/2010.
  • [F6]The option is exercisable in five equal annual installments beginning on 2/20/2008.
  • [F7]The option is exercisable in five equal annual installments beginning on 2/21/2007.
  • [F8]The option is exercisable in four equal annual installments beginning on 02/21/2013.
  • [F9]The option is exercisable in five equal annual installments beginning on 02/22/2006.

Documents

1 file
  • 4
    doc4.xmlPrimary